Artwork

Kandungan disediakan oleh Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !

Ep72: Investing in the Future of Digital Therapeutics: Opportunities and Challenges in the Market

37:25
 
Kongsi
 

Manage episode 373589728 series 2857558
Kandungan disediakan oleh Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

In this episode, we hear from David Kim, Managing Director at DigiTx Partners. In their own words DigiTX Partners is a venture firm focused on investing in and supporting early stage startup companies in the digital health space. Launched in 2016 as a joint venture by Astellas Pharma And MPM Capital, DigiTx Partners remains one of a few venture funds exclusively dedicated to the digital health space. In 2018, Astellas continued its endeavor in digital health by forming the Rx Plus Digital Fund with DigiTx Partners as its investment manager.

In this episode, we cover:

  • What are the challenges faced by digital therapeutics in terms of distribution and clinical workflow?
  • What hypothesis does DigiTx on DTx?
  • What are the benefits of standalone vs drug+? Are DigiTx tracking any other modalities?
  • What lessons have DigiTx learned so far?
  • What will be the drivers for new capital injections in DTx especially? What are investors looking for ?
  • What will the drivers of success going forward be for DTx?
  • How will the role of doctors, nurse & pharmacists change in order for the industry overall to scale PDT's?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 episod

Artwork
iconKongsi
 
Manage episode 373589728 series 2857558
Kandungan disediakan oleh Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

In this episode, we hear from David Kim, Managing Director at DigiTx Partners. In their own words DigiTX Partners is a venture firm focused on investing in and supporting early stage startup companies in the digital health space. Launched in 2016 as a joint venture by Astellas Pharma And MPM Capital, DigiTx Partners remains one of a few venture funds exclusively dedicated to the digital health space. In 2018, Astellas continued its endeavor in digital health by forming the Rx Plus Digital Fund with DigiTx Partners as its investment manager.

In this episode, we cover:

  • What are the challenges faced by digital therapeutics in terms of distribution and clinical workflow?
  • What hypothesis does DigiTx on DTx?
  • What are the benefits of standalone vs drug+? Are DigiTx tracking any other modalities?
  • What lessons have DigiTx learned so far?
  • What will be the drivers for new capital injections in DTx especially? What are investors looking for ?
  • What will the drivers of success going forward be for DTx?
  • How will the role of doctors, nurse & pharmacists change in order for the industry overall to scale PDT's?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 episod

Semua episod

×
 
Loading …

Selamat datang ke Player FM

Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.

 

Panduan Rujukan Pantas

Podcast Teratas